← All trials
NCT05265091
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2021
- Primary completion
- May 30, 2025
- Completion date
- May 30, 2025
- First posted
- Mar 3, 2022
- Last posted
- Oct 13, 2022
- Enrollment
- 414
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.Lead sponsor
- Nanchang UniversityOverall official - principal investigator
- Tianjin Medical UniversityOverall official - principal investigator
- Shantou UniversityOverall official - principal investigator
- Hebei Medical UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.